Items Tagged ‘coronary heart disease’
March 17, 2021
Data show clear benefit from genetic testing before prescribing antiplatelet therapy
By Susan Murphy 
By Terri Malloy Pharmacogenomics is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy and avoid side effects. New research, funded in part by the National Heart, Lung and Blood Institute (NHLBI), shows a clear advantage of genetic testing in helping health care providers […]
Tags: antiplatelet, antiplatelet medication, coronary heart disease, Genetic Testing, pharmacogenomics
April 14, 2017
Precision care for heart disease – a practical approach
By Sharon Rosen
Heart disease can sometimes be a silent killer. Many of us know seemingly healthy people who’ve suddenly or unexpectedly had a heart attack. It can be shocking when people who are at a a healthy weight and exercise regularly die from heart disease that they never knew they had. Many forms of heart disease can […]
Tags: #atrial fibrillation, #cardiology, #Dr. Iftkhar Kullo, #Dr. John Giudicessi, #Dr. Michael Ackerman, #drug-gene reactions, #familial cardiovascular diseases, #sudden cardiac death, #targeted therapies, center for individualized medicine, coronary heart disease, Genetic Testing
December 1, 2015
Genetic Risk Information for Coronary Heart Disease Leads to Lower Bad Cholesterol
By Jeff Briggs
A group of researchers led by Mayo Clinic, and with substantive support from to the Center for Individualized Medicine, has discovered that disclosing genetic risk for coronary heart disease (CHD) results in lower low-density lipoprotein cholesterol (LDL), also known as bad cholesterol. The findings of the Myocardial Infarction Genes (MI-GENES) study were presented recently at […]
Tags: center for individualized medicine, CHD, cholesterol, coronary heart disease, Dr. Iftikhar Kullo, eMERGE, eMERGE Network, LDL (bad) cholesterol, MI-GENES